Abstract: Copolymer additives for crude oils, crude oil mixtures of the copolymer additives and crude oils, and methods for producing or forming the crude oil mixtures are provided. The crude oil mixtures and methods comprise at least copolymer additive introduce or applied to crude oil, wherein the at least one copolymer additive comprises one or more copolymers of vinylpyrrolidone and one or more alpha-olefins.

Abstract: Citrate polyester additives for crude oils, mixtures of the citrate polyester additives and crude oils, and methods for producing or forming the mixtures are provided. The mixtures and methods comprise at least one citrate polyester additive introduce or applied to crude oil, wherein the at least one citrate polyester additive comprises one or more citrate crosspolymers.

Abstract: A method of treating petroleum fluids includes adding a wax inhibitor composition to the petroleum fluids, the wax inhibitor composition, including a wax inhibitor; a non-ionic surfactant or a cationic surfactant; and a co-solvent blend. A method of treating a petroleum fluid, includes adding a wax inhibitor composition to the petroleum fluid, the wax inhibitor composition including a wax inhibitor; an anionic surfactant selected from at least one of an isopropylamine dodecylsulfonic acid salt or an isopropylamine linear dodecylbenzene sulfonate; and a co-solvent blend.

Abstract: Embodiments relate to fluid flow improvers containing a copolymer with a siloxane group incorporated thereto. The fluid flow improvers may include polymer/copolymer having the characteristic of inhibiting wax/paraffin crystalline growth, modifying wax/paraffin crystal growth, dispersing of wax/paraffin, preventing the deposition of wax/paraffin, aiding the removal of wax/paraffin or depressing of the pour point of a wax/paraffin-containing fluid. The fluid flow improvers described may be employed alone, or may be used in combination with one or more additives for improving the low temperature flowability and/or other properties and may also be employed in combination with one or more organic solvents and/or aqueous solvents.

Abstract: Embodiments relate to fluid flow improvers containing a copolymer with a siloxane group incorporated thereto. The fluid flow improvers may include polymer/copolymer having the characteristic of inhibiting wax/paraffin crystalline growth, modifying wax/paraffin crystal growth, dispersing of wax/paraffin, preventing the deposition of wax/paraffin, aiding the removal of wax/paraffin or depressing of the pour point of a wax/paraffin-containing fluid. The fluid flow improvers described may be employed alone, or may be used in combination with one or more additives for improving the low temperature flowability and/or other properties and may also be employed in combination with one or more organic solvents and/or aqueous solvents.

Abstract: A method is provided for preparing a biologically active molecule having an increased serum half-life. The method involves conjugating a polymer such as polyethylene glycol to the biologically active molecule. Also provided are polypeptide drugs having an increased serum half-life, e.g., human urokinase plasminogen activator (human “uPA” or “hUPA”) or a fragment or derivative thereof. Pharmaceutical compositions containing such molecules and methods of using them to treat uPA-mediated and uPA receptor-mediated disorders are also provided.

Abstract: A method is provided for preparing a biologically active molecule having an increased serum half-life. The method involves conjugating a polymer such as polyethylene glycol to the biologically active molecule. Also provided are polypeptide drugs having an increased serum half-life, e.g., human urokinase plasminogen activator (human “uPA” or “hUPA”) or a fragment or derivative thereof. Pharmaceutical compositions containing such molecules and methods of using them to treat uPA-mediated and uPA receptor-mediated disorders are also provided.

Abstract: A diaphragm pump head with a non-resilient seal comprising: a valve head and a mating valve cover forming a diaphragm chamber. A pump diaphragm forming at least a part of a wall of the diaphragm chamber with the valve cover including an inlet passage leading from a pump input port and through an inlet valve to the diaphragm chamber, and an outlet passage leading from the diaphragm chamber and through an outlet valve to a pump outlet port. The inlet valve and the outlet valve each include a valve diaphragm, and an inlet non-resilient seal and an outlet non-resilient seal. Each non-resilient seal including first and second annular diaphragm seating faces formed in mating faces of the valve body and the valve cover surrounding the inlet passage and the outlet passage and a non-resilient, deformable valve diaphragm entrapped between the first and second diaphragm seating faces.

Abstract: A high density animal housing system with an air source conduit and an air exhaust conduit is normally coupled to one or more ventilating animal cage racks through standard inlet/outlet fittings. A euthanasia fixture is coupled into the standard inlet/outlet fittings and selectively and sequentially operates valves and/or blowers to switch from supply of respiration air to a gas supply, to open and close the flow to the exhaust and to resume ventilation afterwards, for venting. The sequence is timed and controlled by a programmable controller that activates the associated blowers and valves automatically to follow a user selected sequence. The system anesthetizes and then euthanizes the animals via the same flow conduits that otherwise supply respiration air, requiring no rack modifications and little if any human attention other than to couple the rack to the ventilation system at the euthanasia fixture. Operator inputs allow selection among sequences.

Abstract: A method is provided for preparing a biologically active molecule having an increased serum half-life. The method involves conjugating a polymer such as polyethylene glycol to the biologically active molecule. Also provided are polypeptide drugs having an increased serum half-life, e.g., human urokinase plasminogen activator (human “uPA” or “hUPA”) or a fragment or derivative thereof. Pharmaceutical compositions containing such molecules and methods of using them to treat uPA-mediated and uPA receptor-mediated disorders are also provided.

Abstract: A method is provided for preparing a biologically active molecule having an increased serum half-life. The method involves conjugating a polymer such as polyethylene glycol to the biologically active molecule. Also provided are polypeptide drugs having an increased serum half-life, e.g., human urokinase plasminogen activator (human “uPA” or “hUPA”) or a fragment or derivative thereof. Pharmaceutical compositions containing such molecules and methods of using them to treat uPA-mediated and uPA receptor-mediated disorders are also provided.

Abstract: A base synthesis process and catalyst for the preparation of pyridine or its alkylpyridine derivatives involving the catalytic reaction of one or more aldehydes and/or ketones containing from one to about five carbon atoms, with at least one reactant having more than one carbon atom, with ammonia in the gas phase. The catalyst comprises an effective amount of a large-pore zeolite having been prepared with a silica to alumina ratio of at least 15, and at least a first dimension having first channels formed by twelve-membered rings, and a second dimension having second channels formed by ten- or twelve-membered rings which intersect the first channels. The preferred zeolite is a zeolite having the structure of zeolite beta.

Abstract: Lens meter and method of measurement of progressive multifocal lens using the same which is able to set the amount of movement of the lens and to simply position a far- or near-distance refraction characteristics-measuring portion of a progressive multifocal lens. In accordance with the method the optical center of a lens is first found from measurement employing the lens and using the optical center as point of origin, the lens is moved by a distance up to the far-distance refraction characteristics measuring portion and the near-distance refraction characteristics measuring portion of the lens mentioned by the lens manufacturer, so as to effect alignment with the measurement optical axis of the lens meter, thereby measuring the refraction characteristics of each measuring portion.

Abstract: The invention relates to vacuum fluorescent devices having a grid element positioned between the filament and fluorescent anodes of the device. An insulating material on a portion of the grid is effective to reduce grid current and to enable achievement of greater brightness of fluorescence from the fluorescent anodes.